- Ticker
- CHE
- Price
- 498.94
- Stock movement down
- -0.53 (-0.11%)
- Company name
- Chemed Corporation
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Medical Care Facilities
- Market cap
- 7.47B
- Ent value
- 8.09B
- Price/Sales
- 3.49
- Price/Book
- 11.20
- Div yield
- 0.29%
- Div growth
- 6.96%
- Growth years
- 12
- FCF payout
- 8.78%
- Trailing P/E
- 27.94
- Forward P/E
- 23.58
- PEG
- 2.85
- EPS growth
- 19.00%
- 1 year return
- 3.35%
- 3 year return
- 14.46%
- 5 year return
- 19.59%
- 10 year return
- 23.60%
Last updated: 2022-05-13
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 1.44 |
| Dividend yield | 0.29% |
| Payout frequency | Quarterly |
| Maximum yield | 0.60% |
| Average yield | 0.35% |
| Minimum yield | 0.24% |
| Discount to avg yield | -22.06% |
| Upside potential | -18.08% |
| Yield as % of max yield | 48.31% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 0.29% |
| Current yield distribution | 76.83% |
| Yield at 100% (Min) | 0.24% |
| Yield at 90% | 0.28% |
| Yield at 80% | 0.29% |
| Yield at 50% (Median) | 0.31% |
| Yield at 20% | 0.40% |
| Yield at 10% | 0.48% |
| Yield at 0% (Max) | 0.60% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | 12 years |
| CCC status | Dividend Contender |
| Dividend per share | 1.44 |
| Payout frequency | Quarterly |
| Ex-div date | 25 Feb 2022 |
| EPS (TTM) | 17.86 |
| EPS (1y forward) | 21.16 |
| EPS growth (5y) | 19.00% |
| EPS growth (5y forward) | 9.80% |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| CHE | S&P500 | |
| DGR MR | 5.88% | -16.52% |
| DGR TTM | 5.97% | 4.37% |
| DGR 3 years | 6.47% | 3.88% |
| DGR 5 years | 6.96% | 4.73% |
| DGR 10 years | 8.84% | 8.30% |
| DGR 15 years | 12.48% | 5.82% |
| Time since last change announced | 283 days |
| EPS growth (5y) | 19.00% |
| EPS growth (5y forward) | 9.80% |
Payout ratio
Loading...
Please create a free account or log in to access this chart
Payout ratio data
| EPS coverage | FCF coverage | |
| TTM | 8.19% | 8.78% |
| Average | - | - |
| Forward | 6.81% | - |
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 27.94 |
| Price to OCF | 24.65 |
| Price to FCF | 29.95 |
| Price to EBITDA | 18.08 |
| EV to EBITDA | 19.58 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.49 |
| Price to Book | 11.20 |
| EV to Sales | 3.78 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 14.97M |
| EPS (TTM) | 17.86 |
| FCF per share (TTM) | 16.66 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.14B |
| Gross profit (TTM) | 776.91M |
| Operating income (TTM) | 351.97M |
| Net income (TTM) | 267.32M |
| EPS (TTM) | 17.86 |
| EPS (1y forward) | 21.16 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 36.26% |
| Operating margin (TTM) | 16.43% |
| Profit margin (TTM) | 12.48% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 18.16M |
| Net receivables | 117.32M |
| Total current assets | 184.75M |
| Goodwill | 579.70M |
| Intangible assets | 106.37M |
| Property, plant and equipment | 0.00 |
| Total assets | 1.31B |
| Accounts payable | 64.71M |
| Short/Current long term debt | 267.98M |
| Total current liabilities | 279.65M |
| Total liabilities | 639.05M |
| Shareholder's equity | 666.71M |
| Net tangible assets | -19.37M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 302.97M |
| Capital expenditures (TTM) | 53.63M |
| Free cash flow (TTM) | 249.34M |
| Dividends paid (TTM) | 21.90M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 40.10% |
| Return on Assets | 20.47% |
| Return on Invested Capital | 33.98% |
| Cash Return on Invested Capital | 31.69% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 500.08 |
| Daily high | 506.62 |
| Daily low | 497.84 |
| Daily Volume | 93K |
| All-time high | 556.02 |
| 1y analyst estimate | 576.75 |
| Beta | 0.53 |
| EPS (TTM) | 17.86 |
| Dividend per share | 1.44 |
| Ex-div date | 25 Feb 2022 |
| Next earnings date | 25 Jul 2022 |
Downside potential
Loading...
Downside potential data
| CHE | S&P500 | |
| Current price drop from All-time high | -10.27% | -15.91% |
| Highest price drop | -54.57% | -56.47% |
| Date of highest drop | 10 Oct 2008 | 9 Mar 2009 |
| Avg drop from high | -16.45% | -11.33% |
| Avg time to new high | 24 days | 12 days |
| Max time to new high | 1550 days | 1805 days |
COMPANY DETAILS
Marketcap
7.47B
Marketcap category
Mid-cap
Description
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Employees
14137
Website
SEC filings
CEO
Kevin McNamara
Country
USA
City
Cincinnati
Stock type
Common stock
CCC status
Dividend Contender
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
CINCINNATI, May 11, 2022--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022, at appro...
May 11, 2022
CINCINNATI, May 03, 2022--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2022 Health Care Conference on Tuesday, May 10, 2022, a...
May 3, 2022
How far off is Chemed Corporation ( NYSE:CHE ) from its intrinsic value? Using the most recent financial data, we'll...
May 2, 2022
In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.
April 27, 2022
Chemed (CHE) delivered earnings and revenue surprises of 6.68% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
April 26, 2022
CINCINNATI, April 26, 2022--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, th...
April 26, 2022
CINCINNATI, April 07, 2022--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2022, on Tuesday, April 26, 2022, following the ...
April 7, 2022
Investors are optimistic about robust performance by Chemed's (CHE) Roto-Rooter arm.
April 7, 2022
Chemed Corporation ( NYSE:CHE ) shareholders might be concerned after seeing the share price drop 11% in the last...
March 28, 2022
CINCINNATI, March 09, 2022--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022,...
March 9, 2022
Next page